Chikungunya, a mosquito-borne virus found mainly in tropical and subtropical regions, was locally acquired in New York.

“Antibiotic resistance is widespread and threatening the future of modern medicine,” Dr. Yvan Hutin, director of WHO’s Department of Antimicrobial Resistance, told The New York Times. “Simply put, the ...

New code E11.A applies to patients who use lifestyle interventions to show no signs of type 2 diabetes for at least 3 months.

Implementation of a new definition of obesity proposed by a recent Lancet Commission increases the prevalence of obesity.

The FDA has accepted for review the sBLA for Afrezza (insulin human) inhalation powder in children and adolescents with type 1 or 2 diabetes.

Topline data were announced from two phase 3 trials evaluating orforglipron, an oral GLP-1 receptor agonist, in patients with type 2 diabetes.

The label update provides an option for patients who have received at least 1 approved systemic therapy if TNF blockers are clinically inadvisable.

Prior upper endoscopy within 3 years of diagnosis is linked to earlier-stage gastric cancer detection and improved overall and cancer-specific survival among older adults.

Individuals with irritable bowel syndrome have a significantly higher risk of developing ulcerative colitis or Crohn disease.

Following Medicaid expansion, 5-year survival improved among individuals with cancer residing in rural and high-poverty communities.

Pregnant patients with heart failure should receive counseling, specialist care, and appropriate fetal heart monitoring.

A recurrence risk of less than 0.5% at 6 years after surgery may provide a practical definition of “cure” in the setting of colon cancer.